Aminoglycoside‐Resistance Mechanisms for Cystic FibrosisPseudomonas aeruginosaIsolates Are Unchanged by Long‐Term, Intermittent, Inhaled Tobramycin Treatment

Abstract

Aminoglycoside-resistance mechanisms were characterized in Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients during a recent clinica